Announcements Trials
Browse Landscape

Status

Recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1043INDUSTRY 246NETWORK 87NIH 70OTHER_GOV 33UNKNOWN 2INDIV 1FED 1

Study Type

Interventional 14Observational 2

Sponsor

Cancer Type

Gastrointestinal 13Breast 10Thoracic 5Tumor-Agnostic 3Lymphoid 2Head & Neck 2CNS 2Other solid neoplasm 1Gynecologic 1Dermatologic 1

Conditions

Lymphoma, Large B-Cell, Diffuse 2Neoplasms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
UNKNOWN × Observational × Lymphoid × Clear all
NCT06625203 2024-10-03

MOSAIC

OWKIN

Recruiting
7,000 enrolled
Lymphoid

Neoplasms, Lymphoma, Large B-Cell, Diffuse

NCT04491721 2020-07-29

Follow-up the OS and PFS of Rituximab Biosimilar HLX01 and MabThera, in Untreated Subjects With CD20+ DLBCL

ChineseAMS

Enrolling by invitation
407 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡